Fitch Affirms Aurobindo Pharma at 'A+(ind)/F1+(ind)'
Fitch Affirms Aurobindo Pharma at 'A+(ind)/F1+(ind)'
Business Standard - 32 minutes ago
Fitch Ratings has today affirmed India's Aurobindo Pharma Ltd's (APL) National Long-term rating at 'A+(ind)'. The Outlook remains Stable. At the same time, Fitch has affirmed and assigned ratings ...
- Login or register to post comments
- 66 reads
- Feed: News for Pfizer Inc. - Google Finance
- Feed: Aurobindo Pharma News
- Original article
